This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Product Information

LISDEXAMFETAMINE 20 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $2.5969 per EA under NDC 00406511201. Its NADAC has been published 152 times since Sep 27, 2023.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 20 MG CAPSULE

Lisdexamfetamine Dimesylate
$2.5969per EA
DEA Schedule CII

Strength

20 mg/1

Manufacturer

SpecGx LLC

NDC

00406511201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211840

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 20 MG CAPSULE has been published 152 times since Sep 27, 2023, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.

Current price$2.5969 per EA
All-time high$6.3894 (Apr 10, 2024)
All-time low$2.5589 (Apr 22, 2026)
52-week high$3.7220
52-week low$2.5589
Median price$3.8659
Average price$3.9278
Largest weekly change+47.2% (Jun 19, 2024)
Weeks tracked152
Tracking sinceSep 27, 2023

Price History

1W

-5.4%

1M

-5.4%

3M

-4.9%

6M

-8.3%

1Y

-30.2%

3Y

N/A

5Y

N/A

All

-20.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 20 MG CAPSULE, manufactured by SpecGx LLC, is $2.5969 per EA (NDC 00406511201), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 20 MG CAPSULE has declined 20.8%. It has been tracked across 152 weekly CMS publications since Sep 27, 2023.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 20 MG CAPSULE?

Since Sep 27, 2023, the NADAC for LISDEXAMFETAMINE 20 MG CAPSULE has ranged from a low of $2.5589 (Apr 22, 2026) to a high of $6.3894 (Apr 10, 2024), with a median of $3.8659 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 20 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 20 MG CAPSULE?

LISDEXAMFETAMINE 20 MG CAPSULE (NDC 00406511201) is labeled by SpecGx LLC, and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 20 MG CAPSULE in shortage?

Yes — NDC 00406511201 is currently listed in FDA's drug shortage database (posted Jul 14, 2023).